Antibiotic resistance in sepsis patients: Evaluation and recommendation of antibiotic use

North American Journal of Medical Sciences

Volumn 5, Issue 6, 2013, Pages 344-352

  Pradipta, Ivan Surya ^a   Sodik, Dian Chairunnisa ^a   Lestari, Keri ^a   Parwati, Ida ^a   Halimah, Eli ^a   Diantini, Ajeng ^a   Abdulah, Rizky ^a  

^a PADJADJARAN UNIVERSITY   (Indonesia)

Author keywords

Antibiotic resistance; Bacteremia; Sepsis; Systemic infection

Indexed keywords

CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; ERYTHROMYCIN; LEVOFLOXACIN;

ABDOMINAL INFECTION; ADULT; AGE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; ESCHERICHIA COLI; FEMALE; GENDER; HUMAN; KLEBSIELLA PNEUMONIAE; LENGTH OF STAY; LUNG INFECTION; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; RETROSPECTIVE STUDY; SEPSIS; SOFT TISSUE INFECTION; STAPHYLOCOCCUS HOMINIS; URINARY TRACT INFECTION;

EID: 84879542773     PISSN: 22501541     EISSN: 19472714     Source Type: Journal    
DOI: 10.4103/1947-2714.114165     Document Type: Article

References (47)

1. thed. New York: McGraw-Hill; 2005. p. 1920-1.
2. Levy MM. Introduction. In: Daniels R, editor. ABC of sepsis. Chichester: Wiley-Blackwell; 2010. p. 1.
3. Sudjito, Usman H, Joewono S, Suharto AR, Eddy S. The prognostic factors in sepsis. Folis Med Indones 1998;34:14-20.
4. Pradipta IS. Evaluation of antibiotic use in sepsis patients at ward of internal medicine Dr. Sardjito Hospital, Yogyakarta September-November 2008, M. Sc Thesis, Faculty of Pharmacy, Universitas Gadjah Mada, Indonesia. 2009.
5. Bochud YP, Glauser PM, Calandra T. Antibiotics in sepsis. Intensive Care Med 2001;27:S33-48.
6. Orsini J, Mainardi C, Muzylo E, Karki N, Cohen N, Sakoulas G. Microbiological profile of organisms causing bloodstream infection in critically ill patients. J Clin Med Res 2012;4:371-7.
7. Suharjo JB, Cahyono J. Terapi antibiotik empiris pada pasien sepsis berdasarkan organ terinfeksi. Dexa Media 2007;20:85-90.
8. nded. Geneva: World Health Organization; 2003. p. 20-150.
9. Clinical and Laboratory Standard Institute. M100-S17 Performance standard for Antimicrobial Susceptibility testing. Fifteenth Informational Supplement. PA: Villanova; 2005.
10. Garnacho-Montero J, Ortiz-Leyba C, Herrera-Melero I, Aldabo-Pallas T, Cayuela-Dominguez A, Marquez-Vacaro JA, et al. Mortality and morbidity attributable to inadequate empirical antimicrobial therapy in patients admitted to the ICU with sepsis: A matched cohort study. J Antimicrob Chemother 2008;61:436-41.
11. Degoricija V, Sharma M, Legac A, Gradiser M, Sefer S, Vucicevic Z. Survival analysis of 314 episodes of sepsis in medical intensive care unit in university hospital: Impact of intensive care unit performance and antimicrobial therapy. Croat Med J 2006;47:385-97.
12. Carbajal-Guerrero J, Cayuela-Dominguez A, Fernandez-Garcia E, Aldabo-Pallas T, Marquez-Vacaro JA, Ortiz-Leyba C, et al. Epidemiology and long-term outcome of sepsis in elderly patients. Med Intensiva 2013; S0210:377-4.
13. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003;348:1546-54.
14. Wichmann MW, Inthorn D, Andress HJ, Schildberg FW. Incidence and mortality of severe sepsis in surgical intensive care patients: The influence of patient gender on disease process and outcome. Intensive Care Med 2000;26:167-72.
15. Adrie C, Azoulay E, Francais A, Clec'h C, Darques L, Schwebel C, et al. Influence of gender on the outcome of severe sepsis: A reappraisal. Chest 2007;132:1786-93.
16. Eachempati SR, Hydo L, Barie PS. Gender-based differences in outcome in patients with sepsis. Arch Surg 1999;134:1342-7.
17. Berkowitz DM, Martin GS. Sepsis and sex: Can we look beyond our hormones? Chest 2007;132:1725-7.
18. Reade MC, Angus DC. Epidemiology of sepsis and Non-infectious SIRS. In: Cavaillon JM, editor. Sepsis and non-infection systemic inflamation, from biology to critical care. Weinheim: Wiley-VCH Verlag GMbH and Co. KGaA; 2009. p. 13-27.
19. Azevedo JR, Torres OJ, Czeczko NG, Tuon FF, Nassif PA, Souza GD. Procalcitonin as a prognostic biomarker of severe sepsis and septic shock. Rev Col Bras Cir 2012;39:456-61.
20. Nnanna II, Ehis OJ, Sidiquo II, Nnanna IG, Adekunle O. Serum procalcitonin: Early detection of neonatal bacteremia and septicemia in a tertiary healthcare facility. N Am J Med Sci 2011;3:157-60.
21. Adib M, Bakhshiani Z, Navaei F, Saheb Fosoul F, Fouladi S, Kazemzadeh H. Procalcitonin: A reliable marker for the diagnosis of neonatal sepsis. Iran J Basic Med Sci 2012;15:777-82.
22. Fares M, Mourad S, Rajab M, Rifai N. The use of C-reactive protein in predicting bacterial co-Infection in children with bronchiolitis. N Am J Med Sci 2011;3:152-6.
23. Esteban A, Frutos-Vivar F, Ferguson ND, Peñuelas O, Lorente JA, Gordo F, et al. Sepsis incidence and outcome: Contrasting the intensive care unit with the hospital ward. Crit Care Med 2007;35:1284-9.
24. Cahyono JB. Terapi antibiotika empiris pada sepsis berdasarkan orgam terinfeksi. Dexa Media 2007;20:85-90.
25. Wang HE, Shapiro NI, Angus DC, Yealy DM. National estimates of severe sepsis in United States emergency departments. Crit Care Med 2007;35:1928-36.
26. Brun-Buisson C, Doyon F, Carlet J. Bacteremia and severe sepsis in adults: A multicenter prospective survey in ICUs and wards of 24 hospitals. French bacteremia-sepsis study group. Am J Respir Crit Care Med 1996;154:617-24.
27. Cohen J, Carlet J. INTERSEPT: An international, multicenter, placebo-controlled trial of monoclonal antibody to human tumor necrosis factor-alpha in patients with sepsis. International Sepsis Trial Study Group. Crit Care Med 1996;24:1431-40.
28. Sands KE, Bates DW, Lanken PN, Graman PS, Hibberd PL, Kahn KL, et al. Epidemiology of sepsis syndrome in 8 academic medical centers. JAMA 1997;278:234-40.
29. thed. New York: McGraw-Hill; 2005. p. 2137.
30. Bugano DD, Camargo LF, Bastos JF, Silva E. Antibiotic management of sepsis: Current concepts. Expert Opin Pharmacother 2008;9:2817-28.
31. Abad CL, Kumar A, Safdar N. Antimicrobial therapy of sepsis and septic shock: When are two drugs better than one? Crit Care Clin 2011;27:e1-27.
32. Baudouin S. Sepsis competency based critical care. London: Springer Verlag; 2008. p. 63-9.
33. thed. USA: McGraw-Hill; 2008. p. 1695.
34. Paul M, Shani V, Muchtar E, Kariv G, Robenshtok E, Leibovici L. Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis. Antimicrob Agents Chemother 2010;54:4851-63.
35. Fagon JY, Chastre J, Wolff M, Gervais C, Parer-Aubas S, Stéphan F, et al. Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia. A randomized trial. Ann Intern Med 2000;132:621-30.
36. Petrovici CG, Dorobǎţ C, Matei M, Teodor A, Luca V, Miftode E. Aspects of the antimicrobial resistence profile in infections with Escherichia coli and Klebsiella pneumoniae in diabetic patients. Rev Med Chir Soc Med Nat Iasi 2011;115:769-75.
37. Nataro JP, James BK. Diarrheagenic Escherichia coli. Clin Microbiol Rev 1998;11:144.
38. Weinstein MP, Mirrett S, Van Pelt L, McKinnon M, Zimmer BL, Kloos W, et al. Clinical importance of identifying coagulase-negative staphylococci isolated from blood cultures: Evaluation of microscan rapid and dried overnight gram-positive panels versus a conventional reference method. J Clin Microbiol 1998;36:2089-92.
39. Nwose EU. Quality in diagnostic microbiology: Experiential note to emphasize value of internal control program. N Am J Med Sci 2013;5:82-7.
40. Metz-Gercek S, Maieron A, Strauss R, Wieninger P, Apfalter P, Mittermayer H. Ten years of antibiotic consumption in ambulatory care: Trends in prescribing practice and antibiotic resistance in Austria. BMC Infect Dis 2009;9:61.
41. Raymond DP, Pelletier SJ, Crabtree TD, Evans HL, Pruett TL, Sawyer RG. Impact of antibiotic-resistant gram-negative bacilli infections on outcome in hospitalized patients. Crit Care Med 2003;31:1035-41.
42. Paknikar SS, Narayana S. Newer antibacterials in therapy and clinical trials. N Am J Med Sci 2012;4:537-47.
43. Kollef MH, Fraser VJ. Antibiotic resistance in the intensive care unit. Ann Intern Med 2001;134:298-314.
44. Kollef MH. Bench-to-bedside review: Antimicrobial utilization strategies aimed at preventing the emergence of bacterial resistance in the intensive care unit. Crit Care 2005;9:459-64.
45. Kollef MH. Is antibiotic cycling the answer to preventing the emergence of bacterial resistance in the intensive care unit? Clin Infect Dis 2006;43 Suppl 2:S82-8.
46. Hollands JM, Micek ST, McKinnon PS, Kollef MH. Early appropriate empiric therapy and antimicrobial de-escalation. In: Robert C, Owen Jr, Lautenbach E, editors. Antimicrobial resistance problem pathogen and clinical countermeasure. New York: Informa Healthcare; 2008. p. 231-50.
47. Gupta V, Singla N, Gombar S, Palta S, Sahoo T, Chander J. Admission surveillance cultures among patients admitted to intensive care unit. N Am J Med Sci 2012;4:648-50.